Loading clinical trials...
Loading clinical trials...
Holter of Movement in Patients with Multiple Sclerosis. Acti-SEP Study: Uncontrolled Environment.
ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be included on a voluntary basis. The investigators plan to include a group of approximately 80 patients with MS, fulfilling the McDonald's 2017 criteria, of whom 40 of them show a progressive course according to the Lublin classification. The investigators have planned two visits (at baseline and 1 year later). On both visits, participants will perform few tests (timed 25-Foot Walk (T25-FW), 9-Hole Peg Test (9-HPG), 6-minutes walk test (6MWT), Berg balance scale) and will answer to some questionaires (Godin Leisure Time Exercice Questionnaire, multiple sclerosis walking scale, modified fatigue impact scale, Hospital Anxiety and Depression Scale) After each visit, participants will wear Actimyo for three months in daily living.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Centre Hospitalier Universitaire de Liège
Liège, Liège, Belgium
CHR Citadelle
Liège, Liège, Belgium
Antwerp University Hospital
Antwerp, Belgium
CHC Mont Legia
Liège, Belgium
Saint-Luc University Clinics
Woluwe-St. Lambert, Belgium
Hôpital d'instruction des Armées Percy
Clamart, France
Pitié-Salpêtrière Hospital
Paris, France
Start Date
March 9, 2021
Primary Completion Date
February 15, 2026
Completion Date
February 15, 2026
Last Updated
February 12, 2025
80
ESTIMATED participants
Actimyo
DEVICE
Lead Sponsor
Centre Hospitalier Universitaire de Liege
Collaborators
NCT06276634
NCT07225504
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06809192